119 related articles for article (PubMed ID: 23981626)
1. Chemoradiotherapy followed by surgery could improve the efficacy of treatments in patients with resectable esophageal carcinoma.
Wang F; Wang YM; He W; Li XK; Peng FH; Yang XL; Fan QX
Chin Med J (Engl); 2013 Aug; 126(16):3138-45. PubMed ID: 23981626
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma.
Deng J; Wang C; Xiang M; Liu F; Liu Y; Zhao K
Diagn Pathol; 2014 Jul; 9():151. PubMed ID: 25030066
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and network meta-analysis of neoadjuvant therapy combined with surgery for patients with resectable esophageal squamous cell carcinoma.
Huang Y; Wang H; Luo G; Zhang Y; Wang L; Li K
Int J Surg; 2017 Feb; 38():41-47. PubMed ID: 28027995
[TBL] [Abstract][Full Text] [Related]
4. Traditional and cumulative meta-analysis: Chemoradiotherapy followed by surgery versus surgery alone for resectable esophageal carcinoma.
Feng H; Zhao Y; Jing T; Ma J; Zhao Y; Zhang J; Wang C; Li B
Mol Clin Oncol; 2018 Feb; 8(2):342-351. PubMed ID: 29435301
[TBL] [Abstract][Full Text] [Related]
5. [Neoadjuvant chemoradiotherapy combined with operation vs. operation alone for resectable esophageal cancer: Meta-analysis on randomized controlled trials].
Duan X; Yu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jul; 20(7):809-815. PubMed ID: 28722096
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma.
Luo H; Cui YY; Zhang JG; Sun YN; Zheng XL; Yang CL; Ye K; Ge H
Clin Transl Oncol; 2018 Jul; 20(7):889-898. PubMed ID: 29143229
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
8. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma.
Lv J; Cao XF; Zhu B; Ji L; Tao L; Wang DD
World J Gastroenterol; 2009 Oct; 15(39):4962-8. PubMed ID: 19842230
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis.
Jin HL; Zhu H; Ling TS; Zhang HJ; Shi RH
World J Gastroenterol; 2009 Dec; 15(47):5983-91. PubMed ID: 20014464
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials.
Zhao X; Ren Y; Hu Y; Cui N; Wang X; Cui Y
PLoS One; 2018; 13(8):e0202185. PubMed ID: 30138325
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemoradiotherapy could improve survival outcomes for esophageal carcinoma: a meta-analysis.
Wang DB; Zhang X; Han HL; Xu YJ; Sun DQ; Shi ZL
Dig Dis Sci; 2012 Dec; 57(12):3226-33. PubMed ID: 22695886
[TBL] [Abstract][Full Text] [Related]
13. Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials.
Liu B; Bo Y; Wang K; Liu Y; Tang X; Zhao Y; Zhao E; Yuan L
Oncotarget; 2017 Mar; 8(12):20410-20417. PubMed ID: 28099899
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas.
Kato H; Fukuchi M; Manda R; Faried A; Takita J; Nakajima M; Miyazaki T; Sohda M; Fukai Y; Masuda N; Tsukada K; Kuwano H
Anticancer Res; 2004; 24(6):4091-6. PubMed ID: 15736457
[TBL] [Abstract][Full Text] [Related]
15. A single institutional non-randomized retrospective comparison between definitive chemoradiotherapy and radical surgery in 82 Japanese patients with resectable esophageal squamous cell carcinoma.
Yamashita H; Nakagawa K; Yamada K; Kaminishi M; Mafune K; Ohtomo K
Dis Esophagus; 2008; 21(5):430-6. PubMed ID: 19125797
[TBL] [Abstract][Full Text] [Related]
16. A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol.
Chen Y; Zhu Z; Zhao W; Li L; Ye J; Wu C; Tang H; Lin Q; Li J; Xia Y; Li Y; Zhou J; Zhao K
Radiat Oncol; 2018 Feb; 13(1):33. PubMed ID: 29482649
[TBL] [Abstract][Full Text] [Related]
17. Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studies.
Lin G; Han SY; Xu YP; Mao WM
Dis Esophagus; 2016 Nov; 29(8):1107-1114. PubMed ID: 26542065
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta-analysis.
Chan KKW; Saluja R; Delos Santos K; Lien K; Shah K; Cramarossa G; Zhu X; Wong RKS
Int J Cancer; 2018 Jul; 143(2):430-437. PubMed ID: 29441562
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemoradiotherapy or chemotherapy? A comprehensive systematic review and meta-analysis of the options for neoadjuvant therapy for treating oesophageal cancer.
Deng HY; Wang WP; Wang YC; Hu WP; Ni PZ; Lin YD; Chen LQ
Eur J Cardiothorac Surg; 2017 Mar; 51(3):421-431. PubMed ID: 27694253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
